Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inclisiran Response in a Patient With Familial Hypercholesterolemia After Suboptimal Response to Evolocumab.

JACC. Case reports·2026
Same author

Cooperative Binding Domains Enhance Sensitivity and Overcome the Hook Effect in Two-Component Protein Biosensors.

ACS sensors·2026
Same author

Exercise training for the management of dyslipidaemia. A position statement from Exercise and Sports Science Australia (ESSA).

Journal of science and medicine in sport·2025
Same author

Universal newborn screening for familial hypercholesterolaemia-insights from healthcare professionals in Queensland, Australia.

Journal of community genetics·2025
Same author

Exploring Everyday Experiences of Adolescents Living With Asthma Through Bronfenbrenner's Ecological Systems Theory.

Nursing open·2025
Same author

A Clinical Audit of the Use of CT Head Scan Post-Inpatient Falls in Hospitalised Older Adults Utilising a Post-Fall Clinical Pathway.

International journal of environmental research and public health·2025

Related Experiment Video

Updated: Jun 2, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

Development and pilot test of a peer-support based Cardiac-Diabetes Self-Management Program: a study protocol.

Chiung-Jung Jo Wu1, Anne M Chang, Mary Courtney

  • 1School of Nursing and Midwifery, Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD, Australia. c3.wu@qut.edu.au

BMC Health Services Research
|April 13, 2011
PubMed
Summary

This study pilots a new self-management program for cardiac patients with type 2 diabetes, using technology and peer support to improve health outcomes and reduce hospital readmissions.

Related Experiment Videos

Last Updated: Jun 2, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

Area of Science:

  • Cardiology
  • Endocrinology
  • Health Services Research

Background:

  • Patients with cardiac disease and type 2 diabetes have significantly higher hospital readmission rates (22%) than those without diabetes (6%).
  • Effective self-management is crucial for improving health outcomes in this population.
  • A gap exists in tailored self-management programs for individuals with both cardiac conditions and type 2 diabetes.

Purpose of the Study:

  • To develop and pilot test a Cardiac-Diabetes Self-Management Program.
  • To incorporate user-friendly technologies and train lay personnel for patient follow-up support.
  • To evaluate the feasibility and acceptability of the program and peer support model.

Main Methods:

  • A randomized controlled trial involving 30 cardiac patients with type 2 diabetes.
  • Intervention group received the Cardiac-Diabetes Self-Management Program (three face-to-face sessions, telephone, and text-messaging follow-up) alongside usual care.
  • Control group received usual care. Data collected at baseline and one month post-discharge.

Main Results:

  • The study protocol is presented for a randomized controlled trial.
  • Feasibility and acceptability of the Cardiac-Diabetes Self-Management Program and peer support will be evaluated.
  • Primary outcomes include changes in self-efficacy, self-care behavior, and knowledge.

Conclusions:

  • This study protocol outlines the pilot evaluation of a novel Cardiac-Diabetes Self-Management Program.
  • It assesses the feasibility of integrating peer support into patient follow-up.
  • Findings will inform the refinement and future implementation of self-management programs for comorbid cardiac and diabetes conditions.